KREF Q1 net loss widens to $61.9M; distributable loss; dividend slashed to $0.10

KKR Real Estate Finance Trust Inc.

2026-Q1 EPS reported -$0.96

Net loss of $61.9M ($0.96 diluted EPS) vs prior quarter loss of $32M; CECL provision $73.5M.
Distributable loss of $4.1M vs distributable earnings of $14.4M prior quarter; dividend cut to $0.10/share from $0.25.
Book value per share $11.87, inclusive of CECL allowance of $4.03/sh; CECL allowance increased $73.5M.
Originated $184M floating-rate senior loan on UK industrial portfolio; received $415M repayments including $312M on office loans.
Board authorized $75M stock repurchase program for common and preferred; leased REO property in Mountain View to OpenAI.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

KKR Real Estate Finance Trust Inc. reported quarter ended March 31, 2026 results: net income ($61.9) million, or ($0.96) per diluted share of common stock, EPS ($0.96) per diluted share.

Period: quarter ended March 31, 2026
Net income: ($61.9) million, or ($0.96) per diluted share of common stock
EPS: ($0.96) per diluted share
Result: reported results

Exact text from the filing

KKR Real Estate Finance Trust Inc. (the “Company” or “KREF”) (NYSE: KREF) today reported its financial results for the quarter ended March 31, 2026. Reported net loss attributable to common stockholders of ($61.9) million, or ($0.96) per diluted share of common stock, for the three months ended March 31, 2026

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

KKR Real Estate Finance Trust Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-026573

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.